Pubblicato su stage4eu il: 17/06/2020
European Medicines Agency, Trainee (Public and Stakeholders Engagement)
EMA-European Medicines Agency
Domenico Scarlattilaan 6, Amsterdam, Paesi Bassi
10 mesi. Inizio: 1 ottobre 2020
1.360 euro mensili
Benefit: contributo alle spese di viaggio
L'offerta scade il 15/07/2020
A. Driving collaborative evidence generation – improving the scientific quality of evaluations
- Expand benefit-risk assessment and communication - Evaluate the impact and added value of patient involvement in Scientific Advisory Group (SAG) and Ad-hoc expert group meetings. Patients are invited to benefit-risk discussions to provide evidence based on their experience with a condition and its treatment. Results from the work will inform any future process improvement for future SAG/ad hoc expert groups. It is expected to deliver also a scientific publication demonstrating quantitative analysis and added value of patients.
- Reinforce patient relevance in evidence generation - Support the establishment of focus groups in selected therapeutic areas. This new methodology is expected to support patient data collection on areas of unmet needs and to support the further development of patient-reported outcomes and quality of life, that will contribute to assessment of medicines and development of scientific guidelines.
B. Information on medicines for stakeholders
Important medicine-related information is prepared for the general public, such as medicine overviews and safety communications which are reviewed by patients and healthcare professionals prior to publication.
- A pilot study is proposed using a new feedback form to reach out to patients involved in the review of medicine overviews. The feedback gathered will be analysed and used for improving the review process ensuring the feedback received is fit for purpose.
- Review of the literature on best practices for user testing to assess new evidence that could be applicable. The aim is to ensure that information is generated in the most up to date fashion.
- New impact assessment of EMA safety communications for patients and HCPs organisations and actions on optimising dissemination through the communication channels of these organisations
To be eligible for consideration for this placement, you are required to:
- enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
- possess a university degree in pharmacy, medicine, other life science, social science (minimum of three years or more) that must have been obtained within the last 12 months (July 2019 -July 2020) or be a university student on an Erasmus + or a similar programme or a PhD student.
- a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages
For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.
In addition to the eligibility criteria, you will have:
- Good written and spoken communication in English
- Interest in type of information patients, healthcare professionals and the general public need.
- Good editorial, grammatical and proof-reading skills
- Good Excel skills desirable
Stage4eu is free of charge and has no commercial purpose.
It does not conduct brokerage activities, nor does collect CVs.
By clicking on the green button “Vai all’Offerta” you’ll be redirected to the original vacancy posted on host organizations’ web page.